Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Natural history of functional decline in Alzheimer's disease: a systematic review.
Delva F, Auriacombe S, Letenneur L, Foubert-Samier A, Bredin A, Clementy A, Latxague C, Puymirat E, Ballan G, Delabrousse-Mayoux JP, Glénisson L, Mazat L, Spampinato U, Rainfray M, Tison F, Dartigues JF. Delva F, et al. Among authors: bredin a. J Alzheimers Dis. 2014;40(1):57-67. doi: 10.3233/JAD-131862. J Alzheimers Dis. 2014. PMID: 24326518 Review.
Chronic inflammatory demyelinating polyneuropathy: immunopathological and ultrastructural study of peripheral nerve biopsy in 42 cases.
Vital C, Vital A, Lagueny A, Ferrer X, Fontan D, Barat M, Gbikpi-Benissan G, Orgogozo JM, Henry P, Brechenmacher C, Bredin A, Desbordes P, Ribière-Bachelier C, Latinville D, Julien J, Pétry KG. Vital C, et al. Among authors: bredin a. Ultrastruct Pathol. 2000 Nov-Dec;24(6):363-9. doi: 10.1080/019131200750060023. Ultrastruct Pathol. 2000. PMID: 11206333
Paraneoplastic dermatomyositis with glycogen accumulation in muscle.
Lagueny A, Martin-Negrier ML, Bredin A, Berge-Lefranc JL, Piraud M, Vital A. Lagueny A, et al. Among authors: bredin a. Rev Neurol (Paris). 2014 Mar;170(3):229-30. doi: 10.1016/j.neurol.2013.09.009. Epub 2014 Mar 6. Rev Neurol (Paris). 2014. PMID: 24613475 No abstract available.
The impact of age on genetic testing decisions in amyotrophic lateral sclerosis.
Mehta PR, Iacoangeli A, Opie-Martin S, van Vugt JJFA, Al Khleifat A, Bredin A, Ossher L, Andersen PM, Hardiman O, Mehta AR, Fratta P, Talbot K; Project MinE ALS Sequencing Consortium; Al-Chalabi A. Mehta PR, et al. Among authors: bredin a. Brain. 2022 Dec 19;145(12):4440-4447. doi: 10.1093/brain/awac279. Brain. 2022. PMID: 36162820 Free PMC article.
Impact of the covid-19 pandemic on amyotrophic lateral sclerosis care in the UK.
Musson LS, Collins A, Opie-Martin S, Bredin A, Hobson EV, Barkhouse E, Coulson MC, Stavroulakis T, Gould RL, Al-Chalabi A, McDermott CJ. Musson LS, et al. Among authors: bredin a. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Feb;24(1-2):91-99. doi: 10.1080/21678421.2022.2040533. Epub 2022 Feb 22. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 35189760 Free article.
Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study.
Papeix C, Castelnovo G, Leray E, Coustans M, Levy P, Visy JM, Kobelt G, Lamy F, Allaf B, Heintzmann F, Chouette I, Raponi E, Durand B, Grevat E, Kamar D, Debouverie M, Lebrun-Frenay C; Virgile Study Group. Papeix C, et al. Neurol Ther. 2022 Jun;11(2):633-658. doi: 10.1007/s40120-022-00334-y. Epub 2022 Feb 11. Neurol Ther. 2022. PMID: 35147904 Free PMC article.
12 results